Skip to content

Browse Protocols

Wrote one of these methods? Find yours by DOI and review the entry.

Find your method
934 protocols found
934 protocols found
LIVER
Publication-derived

Liver Assembloids for Drug Screening

Source Skardal et al. · Wake Forest Institute for Regenerative Medicine, Winston-Salem, USA · DOI

Duration: 21 days Cell source: iPSC-Derived (Human iPSC-CMs + Primary Hepatocytes)
Drug screening
No SOP yet
BRAIN
Publication-derived

Brain Organoids for Disease Modelling (2017)

Source Koehler et al. · Indiana University / Boston Children's Hospital / Harvard Medical School, USA · DOI

Duration: 75 days Cell source: Human iPSC / Human ESC Full SOP · 5 phases · QC included
Full SOP with Academic or a plan
BRAIN
Publication-derived

Brain Organoids for Disease Modelling (2020)

Source Muller et al. · Eli Lilly and Company / Indiana University, Indianapolis, IN, USA · DOI

Duration: 40 days Cell source: Human iPSC
Disease modelling
No SOP yet
BRAIN
Publication-derived

Brain 2D Cell Cultures

Source Chambers et al. · Memorial Sloan Kettering Cancer Center, New York, NY, USA · DOI

Duration: 15 days Cell source: Human iPSC / Human ESC
No SOP yet
BRAIN
Publication-derived

Retinal Organoids for Developmental Studies with Single-Cell Profiling

Source Sridhar et al. · University of Washington, Seattle, WA, USA · DOI

Duration: 180 days Cell source: Human ESC / Human iPSC
Developmental biology
No SOP yet
BRAIN
Publication-derived

Retinal Organoids for Developmental Studies (2015)

Source Kuwahara et al. · Nagoya University / Sumitomo Dainippon Pharma, Nagoya & Osaka, Japan

Duration: 120 days Cell source: Human iPSC / Human ESC
Developmental biology
No SOP yet
BRAIN
Publication-derived

Retinal Organoids for Regenerative Medicine

Source Cowan et al. · Institute of Molecular and Clinical Ophthalmology Basel (IOB) / Roche, Switzerland

Duration: 210 days Cell source: Human ESC (GMP-Grade)
Regenerative medicine
No SOP yet
BRAIN
Publication-derived

Retinal Organoids for Disease Modelling with Gene Editing

Source Lane et al. · Moorfields Eye Hospital / UCL Institute of Ophthalmology, London, UK · DOI

Duration: 180 days Cell source: Patient-Derived iPSC (X-linked RP) + CRISPR-Corrected Isogenic
Disease modelling
No SOP yet
BRAIN
Publication-derived

Retinitis Pigmentosa Retinal Organoids

Source Deng et al. · Wenzhou Medical University / National Eye Institute (NEI), China / USA · DOI

Duration: 150 days Cell source: Patient-Derived iPSC (Retinitis Pigmentosa)
Developmental biology
No SOP yet
BRAIN
Publication-derived

Retinal Organoids for Developmental Studies (2019)

Source Capowski et al. · University of Wisconsin-Madison, Madison, WI, USA · DOI

Duration: 175 days Cell source: Human iPSC / Human ESC Full SOP · 4 phases · QC included
Developmental biology
Full SOP with Academic or a plan
BRAIN
Publication-derived

Retinal Organoids for Disease Modelling

Source Zhong et al. · Johns Hopkins University, Baltimore, MD, USA · DOI

Duration: 28 days Cell source: Human iPSC Full SOP · 6 phases · QC included
Disease modelling
Full SOP with Academic or a plan
BRAIN
Publication-derived

Retinal Organoids for Developmental Studies

Source Nakano et al. · RIKEN Center for Developmental Biology, Kobe, Japan

Duration: 60 days Cell source: Human ESC
Developmental biology
No SOP yet
BRAIN
Publication-derived

Spinal Cord Organoids for Developmental Studies

Source Faustino Martins et al. · Max Delbrück Center / Charité, Berlin, Germany · DOI

Duration: 60 days Cell source: Human iPSC + MG Patient Serum
Developmental biology
No SOP yet
BRAIN
Publication-derived

Spinal Cord Organoids

Source Lippmann et al. · Vanderbilt University, Nashville, TN, USA · DOI

Duration: 35 days Cell source: Human iPSC
No SOP yet
BRAIN
Publication-derived

Spinal Cord Organoids for Drug Screening

Source Sances et al. · Cedars-Sinai Medical Center, Los Angeles, CA, USA · DOI

Duration: 50 days Cell source: Patient-Derived iPSC (SMA Type I)
Drug screening
No SOP yet
BRAIN
Publication-derived

Brain Organoids (2024)

Source Trujillo et al. · University of California San Diego (UCSD), La Jolla, CA, USA · DOI

Duration: 200 days Cell source: Human iPSC (Patient-Specific)
Characterisation
No SOP yet
BRAIN
Publication-derived

Brain Organoids for Infection and Disease Modelling

Source Bortolini et al. · University of São Paulo, Brazil / University of California San Diego, USA

Duration: 60 days Cell source: Human iPSC
Infectious disease
No SOP yet
BRAIN
Publication-derived

Brain Organoids for Developmental Studies

Source Sloan et al. · Stanford University / Baylor College of Medicine, Houston, TX, USA · DOI

Duration: 590 days Cell source: Human iPSC
Developmental biology
No SOP yet
BRAIN
Publication-derived

Stroke Brain Models

Source Daviaud et al. · Yale University, New Haven, CT, USA · DOI

Duration: 60 days Cell source: Human iPSC
Drug screening
No SOP yet
BRAIN
Publication-derived

Brain Organoids for Disease Modelling and Long-Term Culture

Source Gordon et al. · University of California Los Angeles (UCLA), Los Angeles, CA, USA · DOI

Duration: 400 days Cell source: Human iPSC
Developmental biology
No SOP yet
BRAIN
Publication-derived

Brain Organoids (2022)

Source He et al. · Harvard University / Broad Institute, Cambridge, MA, USA · DOI

Duration: 90 days Cell source: Human iPSC
Characterisation
No SOP yet
BRAIN
Publication-derived

Brain Organ-on-Chip Models for Drug Screening

Source Vatine et al. · Cedars-Sinai Medical Center, Los Angeles, CA, USA / Ben-Gurion University, Israel

Duration: 30 days Cell source: Human iPSC
Drug screening
No SOP yet
BRAIN
Publication-derived

Cerebral Organoids for Disease Modelling with Vasculature

Source Wimmer et al. · Institute of Molecular Biotechnology (IMBA), Vienna, Austria · DOI

Duration: 21 days Cell source: Human iPSC / Human ESC
No SOP yet
BRAIN
Publication-derived

Cortical Organoids for Disease Modelling (2023)

Source Wang et al. · University of California San Diego (UCSD), La Jolla, CA, USA · DOI

Duration: 56 days Cell source: Human iPSC
No SOP yet